MARRA, ANDREA
MARRA, ANDREA
Facoltà Dipartimentale di Ingegneria
An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine
2024-01-01 Marra, A.; Santi, A.; Pucciarini, A.; Venanzi, A.; De Carolis, L.; Zaja, F.; Ascani, S.; Canzonieri, V.; Ballanti, S.; Falini, B.; Tiacci, E.
CD123 is consistently expressed on NPM1-mutated AML cells
2021-01-01 Perriello, V. M.; Gionfriddo, I.; Rossi, R.; Milano, F.; Mezzasoma, F.; Marra, A.; Spinelli, O.; Rambaldi, A.; Annibali, O.; Avvisati, G.; Di Raimondo, F.; Ascani, S.; Falini, B.; Martelli, M. P.; Brunetti, L.
CD47 expression in acute myeloid leukemia varies according to genotype
2023-01-01 Marra, Andrea; Akarca, Ayse U; Martino, Giovanni; Ramsay, Alan; Ascani, Stefano; Perriello, Vincenzo Maria; O'Nions, Jenny; Wilson, Andrew J; Gupta, Rajeev; Childerhouse, Anna; Proctor, Ian; Rodriguez-Justo, Manuel; Pomplun, Sabine; Martelli, Maria Paola; Lo Celso, Cristina; Falini, Brunangelo; Marafioti, Teresa
Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver
2021-01-01 Marra, A.; Martino, G.; Scarpelli, N.; Perriello, V.; Limongello, R.; Ascani, S.
Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade
2025-01-01 Marra, Andrea; Ramsay, Alan; Chamberlain-Keene, Samuel; Soares, Gabriela; Ponzoni, Maurilio; Padmasri, Sugerdana; Rodriguez-Justo, Manuel; Pomplun, Sabine; Proctor, Ian; Childerhouse, Anna; Muntasser, Alsharabati; Cioce, Mario; Fazio, Vito Michele; Ott, German; Piris, Miguel; Falini, Brunangelo; Marafioti, Teresa
Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma
2019-01-01 Marra, A.; Martino, G.; Ascani, S.; Martelli, M. P.; Falini, B.
In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T-Cell Neoplasms
2025-01-01 Manipadam, M. T.; Marra, A.; Ramsay, A.; Padmasri, S.; Gosh, A.; Neves, M.; Bailey, C.; Pomplun, S.; Maciocia, P.; Cwynarski, K.; Ferrari, M.; Lao-Siriex, P.; Piris, M.; Falini, B.; Linch, D.; Rosenwald, A.; Pule, M.; Zamo, A.; Marafioti, T.
Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer Progression
2023-01-01 Cioce, M.; Marra, A.; Rutigliano, D.; Fazio, V. M.
Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6
2024-01-01 Cioce, M.; Gatti, V.; Napolitano, F.; Giorgiano, N. M.; Marra, A.; Portella, G.; Fiorelli, A.; Pentimalli, F.; Fazio, V. M.
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness
2022-01-01 Pirillo, C.; Birch, F.; Tissot, F. S.; Anton, S. G.; Haltalli, M.; Tini, V.; Kong, I.; Piot, C.; Partridge, B.; Pospori, C.; Keeshan, K.; Santamaria, S.; Hawkins, E.; Falini, B.; Marra, A.; Duarte, D.; Lee, C. F.; Roberts, E.; Celso, C. L.
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia
2021-01-01 Limongello, R.; Marra, A.; Mancusi, A.; Bonato, S.; Hoxha, E.; Ruggeri, L.; Hui, S.; Velardi, A.; Pierini, A.
Placental myeloid sarcoma
2020-01-01 Marra, A.; Martino, G.
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
2024-01-01 Santoro, N.; Salutari, P.; Di Ianni, M.; Marra, A.
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML
2022-01-01 Pianigiani, G.; Gagliardi, A.; Mezzasoma, F.; Rocchio, F.; Tini, V.; Bigerna, B.; Sportoletti, P.; Caruso, S.; Marra, A.; Peruzzi, S.; Petito, E.; Spinozzi, G.; Shacham, S.; Landesman, Y.; Quintarelli, C.; Gresele, P.; Locatelli, F.; Martelli, M. P.; Falini, B.; Brunetti, L.
Richter's transformation in the heart
2021-01-01 Marra, A.; Adamo, F.; Baldoni, S.; Laurenti, M. E.; Giansanti, M.; Pasquino, S.; Bigerna, B.; Sorcini, D.; Stella, A.; Guarente, V.; Limongello, R.; Perriello, V.; Martino, G.; Ascani, S.; Falini, B.; Sportoletti, P.
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia
2025-01-01 Venanzi, Alessandra; Cardinali, Valeria; Perriello, Vincenzo; Albano, Francesco; Cimino, Gaetano; Martino, Giovanni; Marra, Andrea; Sportoletti, Paolo; Andresen, Vibeke; T Gjertsen, Bjorn; Sica, Simona; Chiusolo, Patrizia; Paola Martelli, Maria; Tiacci, Enrico; Falini, Brunangelo
Uterine myeloid sarcoma
2020-01-01 Martino, G.; Zanelli, M.; Zizzo, M.; Quintini, M.; Ricci, L.; Marra, A.; Ascani, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An unusual form of BRAF-V600E mutated hairy cell neoplasm with clinical resistance to BRAF inhibition: Challenging precision medicine | 1-gen-2024 | Marra, A.; Santi, A.; Pucciarini, A.; Venanzi, A.; De Carolis, L.; Zaja, F.; Ascani, S.; Canzonieri, V.; Ballanti, S.; Falini, B.; Tiacci, E. | |
| CD123 is consistently expressed on NPM1-mutated AML cells | 1-gen-2021 | Perriello, V. M.; Gionfriddo, I.; Rossi, R.; Milano, F.; Mezzasoma, F.; Marra, A.; Spinelli, O.; Rambaldi, A.; Annibali, O.; Avvisati, G.; Di Raimondo, F.; Ascani, S.; Falini, B.; Martelli, M. P.; Brunetti, L. | |
| CD47 expression in acute myeloid leukemia varies according to genotype | 1-gen-2023 | Marra, Andrea; Akarca, Ayse U; Martino, Giovanni; Ramsay, Alan; Ascani, Stefano; Perriello, Vincenzo Maria; O'Nions, Jenny; Wilson, Andrew J; Gupta, Rajeev; Childerhouse, Anna; Proctor, Ian; Rodriguez-Justo, Manuel; Pomplun, Sabine; Martelli, Maria Paola; Lo Celso, Cristina; Falini, Brunangelo; Marafioti, Teresa | |
| Collision diffuse large B cell lymphoma and myeloid sarcoma in the liver | 1-gen-2021 | Marra, A.; Martino, G.; Scarpelli, N.; Perriello, V.; Limongello, R.; Ascani, S. | |
| Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade | 1-gen-2025 | Marra, Andrea; Ramsay, Alan; Chamberlain-Keene, Samuel; Soares, Gabriela; Ponzoni, Maurilio; Padmasri, Sugerdana; Rodriguez-Justo, Manuel; Pomplun, Sabine; Proctor, Ian; Childerhouse, Anna; Muntasser, Alsharabati; Cioce, Mario; Fazio, Vito Michele; Ott, German; Piris, Miguel; Falini, Brunangelo; Marafioti, Teresa | |
| Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma | 1-gen-2019 | Marra, A.; Martino, G.; Ascani, S.; Martelli, M. P.; Falini, B. | |
| In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T-Cell Neoplasms | 1-gen-2025 | Manipadam, M. T.; Marra, A.; Ramsay, A.; Padmasri, S.; Gosh, A.; Neves, M.; Bailey, C.; Pomplun, S.; Maciocia, P.; Cwynarski, K.; Ferrari, M.; Lao-Siriex, P.; Piris, M.; Falini, B.; Linch, D.; Rosenwald, A.; Pule, M.; Zamo, A.; Marafioti, T. | |
| Mapping Non-Coding RNAs in Space and Time: Another Weapon to Dissect Intra-Tumor Heterogeneity in Cancer Progression | 1-gen-2023 | Cioce, M.; Marra, A.; Rutigliano, D.; Fazio, V. M. | |
| Mesothelioma-Associated Fibroblasts Modulate the Response of Mesothelioma Patient-Derived Organoids to Chemotherapy via Interleukin-6 | 1-gen-2024 | Cioce, M.; Gatti, V.; Napolitano, F.; Giorgiano, N. M.; Marra, A.; Portella, G.; Fiorelli, A.; Pentimalli, F.; Fazio, V. M. | |
| Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness | 1-gen-2022 | Pirillo, C.; Birch, F.; Tissot, F. S.; Anton, S. G.; Haltalli, M.; Tini, V.; Kong, I.; Piot, C.; Partridge, B.; Pospori, C.; Keeshan, K.; Santamaria, S.; Hawkins, E.; Falini, B.; Marra, A.; Duarte, D.; Lee, C. F.; Roberts, E.; Celso, C. L. | |
| Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia | 1-gen-2021 | Limongello, R.; Marra, A.; Mancusi, A.; Bonato, S.; Hoxha, E.; Ruggeri, L.; Hui, S.; Velardi, A.; Pierini, A. | |
| Placental myeloid sarcoma | 1-gen-2020 | Marra, A.; Martino, G. | |
| Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics | 1-gen-2024 | Santoro, N.; Salutari, P.; Di Ianni, M.; Marra, A. | |
| Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML | 1-gen-2022 | Pianigiani, G.; Gagliardi, A.; Mezzasoma, F.; Rocchio, F.; Tini, V.; Bigerna, B.; Sportoletti, P.; Caruso, S.; Marra, A.; Peruzzi, S.; Petito, E.; Spinozzi, G.; Shacham, S.; Landesman, Y.; Quintarelli, C.; Gresele, P.; Locatelli, F.; Martelli, M. P.; Falini, B.; Brunetti, L. | |
| Richter's transformation in the heart | 1-gen-2021 | Marra, A.; Adamo, F.; Baldoni, S.; Laurenti, M. E.; Giansanti, M.; Pasquino, S.; Bigerna, B.; Sorcini, D.; Stella, A.; Guarente, V.; Limongello, R.; Perriello, V.; Martino, G.; Ascani, S.; Falini, B.; Sportoletti, P. | |
| Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia | 1-gen-2025 | Venanzi, Alessandra; Cardinali, Valeria; Perriello, Vincenzo; Albano, Francesco; Cimino, Gaetano; Martino, Giovanni; Marra, Andrea; Sportoletti, Paolo; Andresen, Vibeke; T Gjertsen, Bjorn; Sica, Simona; Chiusolo, Patrizia; Paola Martelli, Maria; Tiacci, Enrico; Falini, Brunangelo | |
| Uterine myeloid sarcoma | 1-gen-2020 | Martino, G.; Zanelli, M.; Zizzo, M.; Quintini, M.; Ricci, L.; Marra, A.; Ascani, S. |